Core Laboratories (NYSE:CLB) Lowered to “Sell” Rating by Wall Street Zen

Core Laboratories (NYSE:CLB) was downgraded by research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Monday.

Separately, Weiss Ratings lowered Core Laboratories from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 4th. Three investment analysts have rated the stock with a Hold rating, According to data from MarketBeat, Core Laboratories presently has an average rating of “Hold” and a consensus price target of $12.00.

Core Laboratories Trading Up 0.1%

Shares of CLB stock opened at $14.24 on Monday. The stock’s fifty day moving average is $15.70 and its two-hundred day moving average is $16.67. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.50 and a current ratio of 2.05. The firm has a market capitalization of $656.23 million, a P/E ratio of 21.90, a PEG ratio of 2.75 and a beta of 0.99. Core Laboratories has a fifty-two week low of $9.72 and a fifty-two week high of $20.36.

Core Laboratories (NYSE:CLB) last announced its quarterly earnings data on Wednesday, April 29th. The oil and gas company reported $0.06 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.06. The company had revenue of $121.80 million for the quarter, compared to analyst estimates of $122.99 million. Core Laboratories had a return on equity of 11.52% and a net margin of 5.94%.The firm’s revenue for the quarter was down 1.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.14 EPS. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS. Research analysts expect that Core Laboratories will post 0.56 earnings per share for the current fiscal year.

Institutional Trading of Core Laboratories

Institutional investors and hedge funds have recently bought and sold shares of the stock. CWA Asset Management Group LLC purchased a new stake in Core Laboratories in the 4th quarter valued at about $9,978,000. Pacific Ridge Capital Partners LLC purchased a new stake in Core Laboratories in the 3rd quarter valued at about $525,000. UBS Group AG raised its holdings in Core Laboratories by 32.9% in the 4th quarter. UBS Group AG now owns 412,515 shares of the oil and gas company’s stock valued at $6,613,000 after buying an additional 102,151 shares during the period. CWM LLC raised its holdings in Core Laboratories by 36.1% in the 4th quarter. CWM LLC now owns 2,516 shares of the oil and gas company’s stock valued at $40,000 after buying an additional 668 shares during the period. Finally, Connable Office Inc. purchased a new stake in Core Laboratories in the 4th quarter valued at about $253,000. 97.81% of the stock is currently owned by hedge funds and other institutional investors.

Core Laboratories News Summary

Here are the key news stories impacting Core Laboratories this week:

• Positive Sentiment: Zacks Research’s longer-term earnings estimates point to improving profitability for Core Laboratories, including FY2027 EPS of $0.83 and FY2028 EPS of $1.10, which is well above the current full-year consensus of about $0.54.
• Positive Sentiment: FY2026 earnings estimates were nudged to $0.57 per share, slightly above the current consensus, suggesting analysts see modest near-term earnings growth.
• Neutral Sentiment: Multiple Zacks Research notes reiterated quarterly EPS expectations for 2026-2028, with no major new corporate announcement; these updates mainly reinforce the existing earnings outlook rather than change it dramatically.
• Neutral Sentiment: Implied volatility in Core Laboratories options has surged, signaling that traders expect a larger-than-usual price move, but the direction of that move is still uncertain. Article Title
• Negative Sentiment: The stock is under pressure despite the upbeat longer-term estimates, likely reflecting investor caution around near-term execution and the broader oilfield-services backdrop.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.